Hemcheck Sweden AB (HEMC) Company Profile

Hemcheck Sweden AB Company Snapshot

Hemcheck Sweden AB operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hemcheck Sweden AB with three other pharmaceutical manufacturers in Europe: Kancera AB (2020 sales of 90,000.00 Swedish Kronor [US$10,430.10 ] ), StenoCare A/S (277,780.14 Swedish Kronor [US$32,191.94 ] ), and Index Pharmaceuticals Holding Ab (35,000.00 Swedish Kronor [US$4,056.15 ] ).

Sales Analysis.

Hemcheck Sweden AB

Stock Data:

Recent Stock Performance:

Current Price (4/1/2021): 3.33
(Figures in Swedish Kronor)

1 Week	2.1%	13 Weeks	-7.2%

4 Weeks	-29.3%	52 Weeks	-12.1%

Hemcheck Sweden AB Key Data:

Ticker:	HEMC	Country:	Sweden

Exchanges:	STO	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Diagnostic Substances

2020 Sales	306,810 (Year Ending Jan 2021).	Employees:	N/A

Currency:	Swedish Kronor	Market Cap:	52,308,406

Fiscal Yr Ends:	December	Shares Outstanding:	15,708,230

Share Type:	Aktie	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.